Episode Details

AMC Entertainment reported its highest quarterly revenue in 106 years for Q2 2026, with adjusted EBITDA surging 70% to a record $321 million and free cash flow hitting $190 million — driven by strong attendance, disciplined cost management, and a blockbuster assist from Christopher Nolan's The Odyssey. For agents, producers, studios, and Wall Street, the numbers reframe a company that spent years being priced as a pre-bankruptcy risk into something more structurally durable.

Key Takeaways:

• Q2 revenue came in just under $1.6 billion — up 14% year-over-year and an all-time record for the 106-year-old chain.
• Adjusted EBITDA hit $321 million, a 70% surge from Q2 2025; net cash from operations rose to $235 million from $138 million.
• AMC refinanced $400 million of debt in Q2, extending maturity by four years, and has reduced principal debt balances by approximately $1.7 billion since end of 2020 — with no maturities expected until 2029.
• The Odyssey opened to $264 million globally; 4.3 million people attended AMC and Odeon theaters in its opening Thursday–Sunday window alone.
• Total attendance rose 13.5% in the quarter (12% domestic, 18% international); food, beverage, and merchandise sales rose 15% globally.
• AMC shares surged more than 20% Monday morning on the earnings release; the stock had traded as low as under $1 in the prior 52-week range.
• The company still posted a net loss of $11.4 million on a GAAP basis, up from $4.7 million a year prior — not yet profitable, but structurally de-risked through at least 2029.

The bankruptcy narrative that has defined AMC for half a decade is now structurally off the table through at least 2029. That changes the negotiating dynamic on theatrical windows, exclusivity deals, and studio-to-exhibitor leverage in meaningful ways. Agents and producers pushing for wide releases have a stronger floor. Studios and streamers who've been negotiating window terms against a distressed counterparty need to recalibrate. Watch how Universal's Odyssey run translates into back-half slate decisions — and whether competing studios accelerate their own wide theatrical bets as a result.

Subscribe to The Option for daily updates on the business behind the business.